InMed Pharmaceuticals (INM) Q4 2022 Earnings

17FebConfirmed
May 22
Sep 22
Nov 22
Q4 2022
-14.03
-9.66
-5.28
-0.91

Details

Expected EPS
N/A
Actual EPS
-0.91
Surprise EPS
-0.91
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (INM) has reported earnings of -0.91 per share for Q4 2022.

0 Comments

Share your thoughts